Research ArticleOriginal Article
Open Access

Clinical effectiveness and safety of fingolimod in relapsing remitting multiple sclerosis in Western Iran

Elham Ouspid, Nazanin Razazian, Abdorreza N. Moghadasi, Nasrin Moradian, Daryoush Afshari, Arash Bostani, Payam Sariaslani and Atefeh Ansarian
Neurosciences Journal April 2018, 23 (2) 129-134; DOI: https://doi.org/10.17712/nsj.2018.2.20170434

Article Information

vol. 23 no. 2 129-134
DOI 
https://doi.org/10.17712/nsj.2018.2.20170434
PubMed 
29664454
Published By 
Neurosciences Journal
Online ISSN 
1658-3183
History 
  • Received March 9, 2017
  • Accepted February 14, 2018
  • Published online November 13, 2020.
Copyright & Usage 
Copyright: © Neurosciences Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

Author Information

  1. Elham Ouspid, MD,
  2. Nazanin Razazian, MD,
  3. Abdorreza N. Moghadasi, MD,
  4. Nasrin Moradian, MD⇑,
  5. Daryoush Afshari, MD,
  6. Arash Bostani, MD,
  7. Payam Sariaslani, MD and
  8. Atefeh Ansarian, MD
  1. From the Department of Neurology (Ouspid, Razazian, Moradian, Afshari, Bostani, Sariaslani), Department of Cardiology (Ansarian), Kermanshah University of Medical Sciences, Kermanshah, and Department of Neurology (Moghadasi), Tehran University of Medical Sciences, Tehran, Iran
  1. Address correspondence and reprint request to: Dr. Nasrin Moradian, Department of Neurology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Islamic Republic of Iran. E-mail: moradiannasrin60{at}yahoo.com
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section